# IntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.

> **NCT06599424** · — · RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 550 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Renal Failure
- Coronary Artery Disease

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT06599424
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10
- **Final completion:** 2025-06
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06599424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06599424, "IntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06599424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*